Update on immunogenicity in severe asthma : experience with mepolizumab
- Author
- Hector G Ortega, Erik Meyer, Guy Brusselle (UGent) , Koichiro Asano, Charlene M Prazma, Frank C Albers, Stephen A Mallett, Steve W Yancey and Gerald J Gleich
- Organization
- Keywords
- SEVERE EOSINOPHILIC ASTHMA, MONOCLONAL-ANTIBODY, DOUBLE-BLIND, MULTICENTER, OMALIZUMAB, BENRALIZUMAB, EFFICACY, SAFETY
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 200.82 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8632749
- MLA
- Ortega, Hector G., et al. “Update on Immunogenicity in Severe Asthma : Experience with Mepolizumab.” JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, vol. 7, no. 7, 2019, pp. 2469–75, doi:10.1016/j.jaip.2019.03.042.
- APA
- Ortega, H. G., Meyer, E., Brusselle, G., Asano, K., Prazma, C. M., Albers, F. C., … Gleich, G. J. (2019). Update on immunogenicity in severe asthma : experience with mepolizumab. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 7(7), 2469–2475. https://doi.org/10.1016/j.jaip.2019.03.042
- Chicago author-date
- Ortega, Hector G, Erik Meyer, Guy Brusselle, Koichiro Asano, Charlene M Prazma, Frank C Albers, Stephen A Mallett, Steve W Yancey, and Gerald J Gleich. 2019. “Update on Immunogenicity in Severe Asthma : Experience with Mepolizumab.” JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE 7 (7): 2469–75. https://doi.org/10.1016/j.jaip.2019.03.042.
- Chicago author-date (all authors)
- Ortega, Hector G, Erik Meyer, Guy Brusselle, Koichiro Asano, Charlene M Prazma, Frank C Albers, Stephen A Mallett, Steve W Yancey, and Gerald J Gleich. 2019. “Update on Immunogenicity in Severe Asthma : Experience with Mepolizumab.” JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE 7 (7): 2469–2475. doi:10.1016/j.jaip.2019.03.042.
- Vancouver
- 1.Ortega HG, Meyer E, Brusselle G, Asano K, Prazma CM, Albers FC, et al. Update on immunogenicity in severe asthma : experience with mepolizumab. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 2019;7(7):2469–75.
- IEEE
- [1]H. G. Ortega et al., “Update on immunogenicity in severe asthma : experience with mepolizumab,” JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, vol. 7, no. 7, pp. 2469–2475, 2019.
@article{8632749,
author = {{Ortega, Hector G and Meyer, Erik and Brusselle, Guy and Asano, Koichiro and Prazma, Charlene M and Albers, Frank C and Mallett, Stephen A and Yancey, Steve W and Gleich, Gerald J}},
issn = {{2213-2198}},
journal = {{JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE}},
keywords = {{SEVERE EOSINOPHILIC ASTHMA,MONOCLONAL-ANTIBODY,DOUBLE-BLIND,MULTICENTER,OMALIZUMAB,BENRALIZUMAB,EFFICACY,SAFETY}},
language = {{eng}},
number = {{7}},
pages = {{2469--2475}},
title = {{Update on immunogenicity in severe asthma : experience with mepolizumab}},
url = {{http://doi.org/10.1016/j.jaip.2019.03.042}},
volume = {{7}},
year = {{2019}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: